Contact
searchSearch
HMP Global
Login
News
Automated Next-Generation Sequencing Assay Demonstrates High Concordance and Reduced Hands-On Time for EGFR and KRAS Mutation Testing for Solid Tumors
11/20/2025
Stephanie Holland
An automated next-generation sequencing workflow for the oncoReveal Dx assay demonstrated strong concordance, reproducibility, and significant efficiency improvements for detecting EGFR and KRAS mutations among patients with solid tumors.
An automated next-generation sequencing workflow for the oncoReveal Dx assay demonstrated strong concordance, reproducibility, and significant efficiency improvements for detecting EGFR and KRAS mutations among patients with solid tumors.
An automated next-generation...
11/20/2025
Oncology
News
Expanded Fusion Panel Helps Identify Potentially Significant Long Noncoding RNA and Other Novel Fusions Across Solid Tumor Types
11/20/2025
Emily Estrada
A retrospective analysis reported novel oncogenic and long noncoding RNA fusions in solid tumor cases, identifying previously unreported rearrangements across multiple tumor types with potential diagnostic and therapeutic relevance.
A retrospective analysis reported novel oncogenic and long noncoding RNA fusions in solid tumor cases, identifying previously unreported rearrangements across multiple tumor types with potential diagnostic and therapeutic relevance.
A retrospective analysis...
11/20/2025
Oncology
News
MET Exon 2 Skipping Mutation Associated With Self-Regulatory Mechanism for Advanced NSCLC
11/20/2025
Emily Estrada
A retrospective analysis presented at the 2025 Association for Molecular Pathology Annual Meeting & Expo found that MET exon 2 skipping mutations are associated with a self-regulatory mechanism among patients with non-small cell lung cancer.
A retrospective analysis presented at the 2025 Association for Molecular Pathology Annual Meeting & Expo found that MET exon 2 skipping mutations are associated with a self-regulatory mechanism among patients with non-small cell lung cancer.
A retrospective analysis...
11/20/2025
Oncology
News
Rapid Agena iPLEX HS Lung Panel Demonstrates High Concordance With Next-Generation Sequencing and Accelerated Turnaround for Precision Treatment for Lung Cancer
11/20/2025
Stephanie Holland
The Agena Bioscience iPLEX HS Lung Panel demonstrated robust analytical performance and rapid turnaround for detecting key molecular alterations among patients with lung cancer.
The Agena Bioscience iPLEX HS Lung Panel demonstrated robust analytical performance and rapid turnaround for detecting key molecular alterations among patients with lung cancer.
The Agena Bioscience iPLEX HS...
11/20/2025
Oncology
News
Whole Transcriptome Sequencing Enhances DNA Variant Detection in Solid Tumors
11/20/2025
Janelle Bradley
Integrating whole transcriptome sequencing with DNA-based analysis in solid tumors enables detection and validation of low-frequency and clinically relevant mutations, resolves sequencing artifacts, and improves the accuracy and efficiency of...
Integrating whole transcriptome sequencing with DNA-based analysis in solid tumors enables detection and validation of low-frequency and clinically relevant mutations, resolves sequencing artifacts, and improves the accuracy and efficiency of...
Integrating whole transcriptome...
11/20/2025
Oncology
News
Idylla Fusion Assay Delivers Rapid, Accurate Gene Fusion Detection in Non-Small Cell Lung Cancer
11/20/2025
Janelle Bradley
In a prospective analysis of 658 NSCLC samples, the Idylla fusion assay demonstrated high sensitivity and specificity for detecting key gene fusions, providing a rapid, automated alternative to NGS for molecular testing in lung cancer.
In a prospective analysis of 658 NSCLC samples, the Idylla fusion assay demonstrated high sensitivity and specificity for detecting key gene fusions, providing a rapid, automated alternative to NGS for molecular testing in lung cancer.
In a prospective analysis of 658...
11/20/2025
Oncology
News
Liquid Biopsy Using Cell-Free Nucleic Acids Enhances Variant Detection in Non-Small Cell Lung Cancer
11/20/2025
Janelle Bradley
In a large-scale study, cell-free nucleic acid sequencing using Ion Torrent AmpliSeq HD and Genexus systems accurately detected key variants across all disease stages in non-small cell lung cancer, demonstrating the clinical utility of liquid...
In a large-scale study, cell-free nucleic acid sequencing using Ion Torrent AmpliSeq HD and Genexus systems accurately detected key variants across all disease stages in non-small cell lung cancer, demonstrating the clinical utility of liquid...
In a large-scale study,...
11/20/2025
Oncology
News
CTNNB1 Co-Mutations Linked to Stronger Osimertinib Response in EGFR-Mutated Non-Small Cell Lung Cancer
11/19/2025
Janelle Bradley
In EGFR-mutated non-small cell lung cancer, patients with CTNNB1 co-mutations showed 100% complete response to osimertinib, while those with TP53 co-mutations had poorer outcomes and higher PD-L1 expression, underscoring the prognostic value...
In EGFR-mutated non-small cell lung cancer, patients with CTNNB1 co-mutations showed 100% complete response to osimertinib, while those with TP53 co-mutations had poorer outcomes and higher PD-L1 expression, underscoring the prognostic value...
In EGFR-mutated non-small cell...
11/19/2025
Oncology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use